Institute of Pharmaceutical Technology and Regulatory Affairs, Faculty of Pharmacy, University of Szeged, Eötvös 6, Szeged H-6720, Hungary.
Department of Medical Microbiology, University of Szeged, Szeged H-6720, Hungary.
Eur J Pharm Sci. 2023 Dec 1;191:106607. doi: 10.1016/j.ejps.2023.106607. Epub 2023 Oct 10.
Periodontitis is one of the most widespread bacterial infectious oral diseases that affects a significant percentage of the population worldwide. Different bacterial strains are responsible for the chronic inflammation and subgingival plaque that could be effectively treated with prolonged exposure to therapeutic levels of antibiotics and antiseptics in the periodontal pockets. Medicated in situ gels of chlorhexidine (CHX), for extended drug release and long-lasting antiseptic effect in the targeted cavities, were prepared in a two-compartment system. One compartment was loaded with sodium alginate solution while other was filled with CHX and calcium solution. The mixing of the solutions during the application resulted in gelation. Two 3 full factorial designs were applied in this study in order to optimize the gel formulation. Initially, the effects of concentration of gelling agent, crosslinker, and pH of the system on the dependent variables such as gel formation and structure characteristics were investigated. Then, the concentration of the crosslinker was optimized. Afterwards, the effect of gelling agent, loading of the drug, and pH of the gel system were correlated with the gel characteristics through another factorial design. Optimized formulations were tested for mucoadhesion, in vitro drug release, and microbiological investigation. Based on the results of the factorial design, mucoadhesiveness, antimicrobial investigation, and drug release, a 4 % alginate composition can be considered optimal. Overall, the optimized in situ periodontal gel was found to be effective with prolonged retention time and desirable outcomes.
牙周炎是一种最广泛的细菌性传染性口腔疾病,影响着全球很大一部分人口。不同的细菌菌株负责引起慢性炎症和龈下菌斑,可以通过延长接触治疗水平的抗生素和防腐剂来有效治疗牙周袋。载有洗必泰(CHX)的局部用原位凝胶,用于在目标腔中延长药物释放和持久的抗菌作用,是在双室系统中制备的。一个隔室装有海藻酸钠溶液,另一个隔室装有 CHX 和钙溶液。在应用过程中,两种溶液的混合导致凝胶化。本研究应用了两个 3 完全因子设计来优化凝胶配方。最初,考察了凝胶剂浓度、交联剂浓度和体系 pH 值对凝胶形成和结构特征等依赖变量的影响。然后,优化了交联剂的浓度。之后,通过另一个因子设计,将凝胶剂浓度、药物载药量和凝胶体系 pH 值与凝胶特性相关联。优化后的配方进行了粘膜粘附性、体外药物释放和微生物学研究。基于因子设计、粘膜粘附性、抗菌研究和药物释放的结果,4%的海藻酸盐组成可以被认为是最佳的。总的来说,优化的局部牙周凝胶具有延长保留时间和理想结果的有效性。